Analysts See $0.94 EPS for Varian Medical Systems, Inc. (VAR)

July 18, 2017 - By Kurt Siggers

 Analysts See $0.94 EPS for Varian Medical Systems, Inc. (VAR)
Investors sentiment increased to 0.9 in 2016 Q4. Its up 0.01, from 0.89 in 2016Q3. It increased, as 38 investors sold Varian Medical Systems, Inc. shares while 188 reduced holdings. 59 funds opened positions while 144 raised stakes. 88.84 million shares or 2.22% less from 90.86 million shares in 2016Q3 were reported.
Kornitzer Capital Management Ks holds 25,285 shares. Qv has 458,046 shares. Johnson Fin Group invested in 0.01% or 821 shares. Amg Funds Limited Liability Company stated it has 1.23% in Varian Medical Systems, Inc. (NYSE:VAR). Retail Bank Of Hawaii reported 6,850 shares or 0.06% of all its holdings. Airain Ltd stated it has 0.02% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Amalgamated Bankshares has invested 0.04% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Chevy Chase Trust Incorporated reported 0.04% in Varian Medical Systems, Inc. (NYSE:VAR). 170,516 were accumulated by Neuberger Berman Grp Ltd Liability. Motley Fool Asset Management Limited holds 1.34% or 67,000 shares in its portfolio. Cypress Asset Tx has 0.17% invested in Varian Medical Systems, Inc. (NYSE:VAR). Caisse De Depot Et Placement Du Quebec owns 0.01% invested in Varian Medical Systems, Inc. (NYSE:VAR) for 24,935 shares. Voya Inv Management Limited stated it has 0.01% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Sterling Cap Limited Liability reported 4,950 shares. Northeast Investment accumulated 2,260 shares.

Since February 22, 2017, it had 0 insider buys, and 14 selling transactions for $12.71 million activity. On Monday, June 12 KENNEDY KOLLEEN T sold $110,000 worth of Varian Medical Systems, Inc. (NYSE:VAR) or 1,087 shares. $87,378 worth of Varian Medical Systems, Inc. (NYSE:VAR) shares were sold by KUO JOHN W. GUERTIN TIMOTHY E sold $1.65M worth of stock. 3,589 Varian Medical Systems, Inc. (NYSE:VAR) shares with value of $326,902 were sold by BOSTROM SUSAN L.

Investors wait Varian Medical Systems, Inc. (NYSE:VAR) to report on July, 26. its quarterly earnings Wall Street analysts expect $0.94 EPS, down $0.28 or 22.95 % from last year’s $1.22 same quarter earnings. This translates into $87.61 million profit for VAR giving the stock a 28.19 P/E. This is assuming the current $0.94 EPS is accurate. Varian Medical Systems, Inc.’s Wall Street analysts see 5.62 % EPS growth, taking into account the $0.89 EPS reproted in the previous quarter, The stock decreased 0.18% or $0.19 during the last trading session, reaching $106.01. About 466,948 shares traded. Varian Medical Systems, Inc. (NYSE:VAR) has risen 29.46% since July 18, 2016 and is uptrending. It has outperformed by 12.76% the S&P500.

Varian Medical Systems, Inc. (NYSE:VAR) Ratings Coverage

Among 10 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 4 have Buy rating, 1 Sell and 5 Hold. Therefore 40% are positive. Varian Medical Systems Inc. had 20 analyst reports since August 27, 2015 according to SRatingsIntel. The rating was maintained by RBC Capital Markets on Monday, January 23 with “Sector Perform”. Robert W. Baird maintained it with “Neutral” rating and $99 target in Wednesday, September 28 report. As per Thursday, November 12, the company rating was initiated by Citigroup. The stock has “Sell” rating by Evercore on Thursday, January 26. The stock has “Sector Perform” rating by RBC Capital Markets on Thursday, April 27. The stock has “Outperform” rating by Barrington Research on Tuesday, January 12. Goldman Sachs downgraded the stock to “Sell” rating in Monday, September 28 report. The company was upgraded on Monday, May 8 by Citigroup. Robert W. Baird downgraded Varian Medical Systems, Inc. (NYSE:VAR) rating on Tuesday, October 20. Robert W. Baird has “Neutral” rating and $82 target. RBC Capital Markets maintained Varian Medical Systems, Inc. (NYSE:VAR) rating on Wednesday, June 21. RBC Capital Markets has “Hold” rating and $9600 target.

Varian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The company has market cap of $9.88 billion. The Firm also has Varian Particle Therapy and the activities of the Ginzton Technology Center (GTC). It has a 33.46 P/E ratio. The Company’s VPT business develops, designs, makes, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer.

More recent Varian Medical Systems, Inc. (NYSE:VAR) news were published by: Zacks.com which released: “Varian Rides on Oncology and Proton Therapy Businesses” on June 28, 2017. Also Nasdaq.com published the news titled: “Zacks Industry Outlook Highlights: Varian Medical Systems, Inogen, Edwards …” on July 07, 2017. Gurufocus.com‘s news article titled: “Smithbridge Asset Management Inc Buys InterDigital Inc, McKesson Corp …” with publication date: July 17, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.